Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Precision Optics Corporation, Inc. (POCI:NASDAQ), powered by AI.
Precision Optics Corporation, Inc. is currently trading at $5.89. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Precision Optics Corporation, Inc. on Alpha Lenz.
Precision Optics Corporation, Inc.'s P/E ratio is -6.9.
“Precision Optics Corporation, Inc. trades at a P/E of -6.9 (undervalued) with modest ROE of -51.8%.”
Ask for details →Precision Optics Corporation, Inc. is a leading entity in the field of advanced optical systems design and manufacturing. Specializing in micro-optics and medical instrumentation, the company develops and produces optical products crucial for various applications, including endoscopic devices and robotic surgery systems. Its innovative solutions are essential to the medical technology sector, providing high-resolution imaging and enhanced visualization tools that aid in precision-oriented surgical environments. These products find applications in fields that require intricate, real-time imagery for diagnostic and operative needs. With expertise in designing custom optics and integrating them with electronic devices, Precision Optics Corporation serves as a pivotal supplier to healthcare equipment manufacturers. The company’s contribution extends beyond healthcare, impacting other sectors like aerospace and defense where precision and accuracy are paramount. Located in Gardner, Massachusetts, Precision Optics Corporation continues to advance optical engineering techniques, solidifying its role in enhancing medical imaging technologies across global markets.
“Precision Optics Corporation, Inc. trades at a P/E of -6.9 (undervalued) with modest ROE of -51.8%.”
Ask for details →Precision Optics Corporation, Inc. (ticker: POCI) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 90 employees. Market cap is $40M.
The current price is $5.89 with a P/E ratio of -6.92x and P/B of 3.26x.
ROE is -51.78% and operating margin is -29.08%. Annual revenue is $19M.